- Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedsideDavid Olmos
Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom
Cancer J 16:183-94. 2010..Despite these encouraging results, not all patients benefit from IGF-1R inhibition and consequently there is an urgent need for the identification of predictive markers of response...
- Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones
Sarcoma Unit, Royal Marsden Hospital, London, UK
Am J Clin Oncol 35:351-7. 2012..The aim of this study was to investigate the response rate and progression-free survival in a series of epithelioid sarcoma patients treated with chemotherapy at a single referral center...
- Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsDavid Olmos
Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK
Sarcoma 2011:402508. 2011..Despite, the initial promising results, not all patients benefit from IGF-1R inhibition, and consequently, there is an urgent need for the identification of predictive markers of response...